AU7154698A - Ngf variants - Google Patents

Ngf variants Download PDF

Info

Publication number
AU7154698A
AU7154698A AU71546/98A AU7154698A AU7154698A AU 7154698 A AU7154698 A AU 7154698A AU 71546/98 A AU71546/98 A AU 71546/98A AU 7154698 A AU7154698 A AU 7154698A AU 7154698 A AU7154698 A AU 7154698A
Authority
AU
Australia
Prior art keywords
ngf
variant
trkc
ngf variant
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU71546/98A
Other languages
English (en)
Inventor
Leonard G Presta
Roman Urfer
John W Winslow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/845,541 external-priority patent/US6333310B1/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AU7154698A publication Critical patent/AU7154698A/en
Priority to AU2002300365A priority Critical patent/AU2002300365B9/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU71546/98A 1997-04-25 1998-04-23 Ngf variants Abandoned AU7154698A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002300365A AU2002300365B9 (en) 1997-04-25 2002-08-01 NGF Variants

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08845541 1997-04-25
US08/845,541 US6333310B1 (en) 1994-06-03 1997-04-25 NGF variants
US84104597A 1997-04-29 1997-04-29
US08841045 1997-04-29
PCT/US1998/008242 WO1998049308A1 (en) 1997-04-25 1998-04-23 Ngf variants

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2002300365A Division AU2002300365B9 (en) 1997-04-25 2002-08-01 NGF Variants

Publications (1)

Publication Number Publication Date
AU7154698A true AU7154698A (en) 1998-11-24

Family

ID=27126232

Family Applications (2)

Application Number Title Priority Date Filing Date
AU71546/98A Abandoned AU7154698A (en) 1997-04-25 1998-04-23 Ngf variants
AU2002300365A Expired AU2002300365B9 (en) 1997-04-25 2002-08-01 NGF Variants

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2002300365A Expired AU2002300365B9 (en) 1997-04-25 2002-08-01 NGF Variants

Country Status (6)

Country Link
EP (1) EP0977860A1 (de)
JP (1) JP2001527402A (de)
AU (2) AU7154698A (de)
CA (1) CA2286558A1 (de)
IL (1) IL132251A0 (de)
WO (1) WO1998049308A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6683058B1 (en) 1998-04-15 2004-01-27 Regents Of The University Of California Methods for therapy of neurodegenerative disease of the brain
US6656474B1 (en) * 1999-01-15 2003-12-02 Regeneron Pharmaceuticals, Inc. Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders
NZ523105A (en) 2000-06-22 2004-07-30 Genentech Inc Agonist anti-trk-C monoclonal antibodies
AU6175801A (en) 2000-07-19 2002-02-05 Univ California Methods for therapy of neurodegenerative disease of the brain
EP1620127A4 (de) * 2003-03-20 2007-04-04 Rinat Neuroscience Corp Verfahren zur behandlung von taxol-induzierten darmstörungen
EP1689865A2 (de) * 2003-10-23 2006-08-16 Monika Holmberg Neues mutiertes gen für nervenwachstumsfaktor-beta, davon codierte proteine sowie produkte und verfahren in verbindung damit
US8309057B2 (en) * 2005-06-10 2012-11-13 The Invention Science Fund I, Llc Methods for elevating neurotrophic agents
ITRM20060367A1 (it) * 2006-07-13 2008-01-14 Lay Line Genomics Spa Muteine del hngf usi terapeutici e composizioni farmaceutiche
IT201800009384A1 (it) * 2018-10-11 2020-04-11 Cosmo Srl Peptide for cosmetic application

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728803A (en) * 1994-06-03 1998-03-17 Genentech, Inc. Pantropic neurotrophic factors

Also Published As

Publication number Publication date
JP2001527402A (ja) 2001-12-25
IL132251A0 (en) 2001-03-19
EP0977860A1 (de) 2000-02-09
AU2002300365B9 (en) 2007-03-15
CA2286558A1 (en) 1998-11-05
WO1998049308A1 (en) 1998-11-05
AU2002300365A1 (en) 2003-01-30
AU2002300365B2 (en) 2006-07-13

Similar Documents

Publication Publication Date Title
US6333310B1 (en) NGF variants
US6365373B2 (en) Nucleic acids encoding NGF variants
US8101571B2 (en) Treatment methods using NGF variants
Urfer et al. The binding epitopes of neurotrophin‐3 to its receptors trkC and gp75 and the design of a multifunctional human neurotrophin.
Battleman et al. HSV-1 vector-mediated gene transfer of the human nerve growth factor receptor p75hNGFR defines high-affinity NGF binding
Laurenzi et al. Expression of mRNA encoding neurotrophins and neurotrophin receptors in rat thymus, spleen tissue and immunocompetent cells: Regulation of neurotrophin‐4 mRNA expression by mitogens and leukotriene B4
CN101123978A (zh) 神经胚素变体
JPH09503999A (ja) 治療剤としてのプロサポシンおよびサイトカイン由来ペプチド
Shen et al. Recent progress in studies of neurotrophic factors and their clinical implications
AU2002300365B2 (en) NGF Variants
US7144983B1 (en) Pantropic neurotrophic factors
AU677979B2 (en) Multifunctional neurotrophic factors
Vantini The pharmacological potential of neurotrophins: a perspective
AU6141599A (en) Method of stimulating prosaposin receptor activity
Cuello Neurotrophins and neurodegenerative diseases
TREANOR et al. Therapeutic Use of Neurotrophic
D DAWBARN et al. Neurotrophins and neurodegenerative

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted